Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 19, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Cetirizine Hydrochloride Syrup...
-
Jun 9, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has filed an Abbreviated New Drug Application (ANDA) for Fluocinonide Cream 0.1%, a generic version of VANOS® Cream 0.1%. The...
-
May 21, 2008Company to Acquire Minority Interest in New Entity
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has entered into a collaborative agreement with Cobrek Pharmaceuticals, a newly formed entity of Pentech Pharmaceuticals Inc., a...
-
May 20, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph C. Papa, Perrigo's Chairman and CEO will present at the Citi Investment Research Global Health Care Conference on Wednesday,...
-
May 6, 2008- Third quarter revenue increased $141 million, or 39 percent, to $504 million on important new product launches
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for its third quarter fiscal year 2008 and nine months ended March 29, 2008. Perrigo Company (in thousands, except per share...
-
May 1, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.05 per share, payable on June 20, 2008 to shareholders of record on May...
-
Apr 24, 2008
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter (OTC) Nicotine Polacrilex...
-
Apr 23, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2008 on Tuesday, May 6, 2008 at approximately 8:00 a.m. (ET). The...
-
Apr 21, 2008
ALLEGAN, Mich., April 21 /PRNewswire-FirstCall/ .- Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has filed an Abbreviated New Drug Application (ANDA) for over-the-counter...
-
Apr 14, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC)...
-
Mar 24, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the 12th Annual Sidoti Emerging Growth Institutional Investor Forum on...
-
Mar 20, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that the United States District Court for the District of New Jersey has denied Connetics Corporation's motion for a preliminary...
-
Mar 11, 2008Court Issues Temporary Restraining Order
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...
-
Mar 6, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its partner, Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA), has received final approval from the U.S. Food and Drug...
-
Mar 4, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has begun shipping 20 mg Omeprazole delayed released tablets to its retail customers. This product delivers the same medicine at...
-
Feb 12, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...
-
Feb 5, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's Chairman and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device...
-
Feb 5, 2008Increases Full Year Guidance
-- Second quarter revenue increased $65 million, or 17 percent, to $435 million -- GAAP net income increased 63 percent to $34 million, or $0.36 per share -- Second quarter cash provided by...
-
Feb 1, 2008
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that the Board of Directors has authorized the repurchase of $150 million of the Company's common stock through February 1, 2010...
-
Jan 22, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its second quarter fiscal 2008 on Tuesday, February 5, 2008 at approximately 8:00 a.m. (ET)....
-
Jan 9, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has acquired Galpharm Healthcare, Ltd. for $86 million in cash. Based in Barnsley, Yorkshire, United Kingdom, privately-held...
-
Jan 4, 2008
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the 26th Annual JPMorgan Healthcare Conference on Wednesday, January 9, at...
-
Dec 28, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for...
-
Dec 10, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that the U.S. Food & Drug Administration (FDA) has granted final approval to Dexcel Pharma Technologies, Ltd. for 20 mg Omeprazole...
-
Nov 1, 2007-- First quarter revenue increased $43 million, or 12 percent, to $383 million
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for its fiscal year 2008 first quarter that ended September 29, 2007. Perrigo Company (in thousands, except per share...
-
Nov 1, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Dexcel Pharma Technologies, Ltd. ("Dexcel"), Perrigo's partner for store brand OTC 20mg Omeprazole delayed release tablet, has...
-
Oct 31, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors appointed President and Chief Executive Officer, Joseph C. Papa, to be Chairman of its Board of Directors....
-
Oct 30, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.05 per share, payable on December 18, 2007 to shareholders of record on...
-
Oct 19, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its first quarter fiscal 2008 on Thursday, November 1, 2007 at approximately 8:00 a.m. (ET)....
-
Sep 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that it had filed an Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg, a generic version of...
-
Sep 19, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market Ciclopirox Topical Solution,...
-
Sep 14, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that President and CEO, Joseph C. Papa and the Perrigo management team will provide a review of the Company business for the financial...
-
Sep 13, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Mori Arkin, Vice Chairman and General Manager, Perrigo Global Generics and API, has advised the Company that he will retire at the...
-
Aug 23, 2007* Full year revenue increased 6 percent to $1.45 billion; earnings per share increased 4 percent to $0.79, and rose 7 percent to $0.89 on a non-GAAP basis
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for fiscal year 2007 and the fourth quarter ended June 30, 2007. Perrigo Company (in thousands, except per share amounts) Fourth...
-
Aug 16, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on September 18, 2007 to shareholders of...
-
Aug 9, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fiscal year 2007 on Thursday, August 23, 2007 at approximately 8:00 a.m. (ET). The Company...
-
Jul 11, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has closed its transaction to acquire Qualis, Inc., a privately-owned manufacturer of store brand pediculicide products for...
-
Jun 20, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that the U.S. Food & Drug Administration (FDA) has granted tentative approval to Dexcel Pharma Technologies, Ltd. (Dexcel) for its...
-
Jun 7, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph C. Papa, Perrigo's President and CEO will present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference on...
-
Jun 6, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that a federal court has ruled in its favor in patent litigation involving Famotidine Complete. Perrigo had been sued by Johnson &...
-
May 30, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex...
-
May 8, 2007Third Quarter Sales $362 million, up 9%
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter of fiscal year 2007 ended March 31, 2007. Perrigo Company (in thousands, except per share amounts)...
-
May 2, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on June 19, 2007 to shareholders of record on...
-
May 1, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May...
-
Apr 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2007 on Tuesday, May 8, 2007 at approximately 8:00 a.m. (ET). The...
-
Apr 5, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the CIBC World Markets Biotechnology & Pharmaceuticals Conference on...
-
Mar 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced an organizational restructuring to further enhance the management of the Company's global operations. John Hendrickson has been named...
-
Mar 7, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has entered into a purchase agreement to acquire Qualis, Inc., a privately-owned manufacturer of store brand pediculicide...
-
Mar 6, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Citigroup Small & Mid-Cap Conference on Tuesday, March 13, at 10:45...
-
Feb 22, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced the appointment by the Board of Directors of Ben-Zion Zilberfarb as a new director of the Company. Dr. Zilberfarb was appointed to...